Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Nonalcoholic Steatohepatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03060538
What this trial is testing

A Multiple Ascending Dose Study to Evaluate Safety and Tolerability of BFKB8488A in Participants With Type 2 Diabetes Mellitus and Participants With Non-Alcoholic Fatty Liver Disease

Who this might be right for
Diabetes Mellitus, Type 2Non-Alcoholic Fatty Liver Disease
Genentech, Inc. 154
Post-approval studies (Phase 4)Not Yet RecruitingNCT07289750
What this trial is testing

The Effect of Alogliptin Combined With Actoplus Met on Glucose and Lipid Metabolism and Pancreatic Function in Patients With T2DM Complicated With MAFLD

Who this might be right for
T2DMMAFLD
The Fourth Affiliated Hospital of Zhejiang University School of Medicine 80
Not applicableStudy completedNCT05317260
What this trial is testing

Steatohepatitis in Chronic Hepatitis B

Who this might be right for
Fatty LiverChronic Hepatitis b
Mahidol University 408
Testing effectiveness (Phase 2)Study completedNCT04618744
What this trial is testing

Assess the Safety and Efficacy of Oral Insulin in T2DM Patients With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Diabetes Mellitus, Type 2NASH - Nonalcoholic Steatohepatitis
Oramed, Ltd. 32
Not applicableUnknownNCT04415632
What this trial is testing

Low GI Diet Effects on Non-Alcoholic Fatty Liver Disease

Who this might be right for
Fatty LiverNutritional and Metabolic Disease
University of Nottingham 16
Testing effectiveness (Phase 2)Ended earlyNCT03827200
What this trial is testing

A Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver Cirrhosis

Who this might be right for
CirrhosisPortal HypertensionAscites
Noorik Biopharmaceuticals AG 19
Not applicableUnknownNCT04463667
What this trial is testing

Impact of Exercise Intervention for Patients With Non-alcoholic Fatty Liver Disease

Who this might be right for
Fatty LiverNAFLD
National Taiwan University Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00586911
What this trial is testing

Betaine in Patients With Nonalcoholic Steatohepatitis

Who this might be right for
Nonalcoholic Steatohepatitis
Mayo Clinic 26
Not applicableLooking for participantsNCT07330830
What this trial is testing

Study of PNPLA3 Genetic Polymorphisms in Patients With Non-Alcoholic Fatty Liver Disease in an Ultramarine Population (AdipoDROMExpo)

Who this might be right for
MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)
Centre Hospitalier Universitaire de la Guadeloupe 600
Not applicableUnknownNCT05513729
What this trial is testing

Effect of Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
Type 2 Diabetes Mellitus With Complication
First Affiliated Hospital Xi'an Jiaotong University 80
Post-approval studies (Phase 4)Study completedNCT04977661
What this trial is testing

Comparing the Effects of Vitamin E, Ursodeoxycholic Acid and Pentoxyfylline on Egyptian Non-alcoholic Steatohepatitis (NASH) Patients

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Kafrelsheikh University 102
Testing effectiveness (Phase 2)Study completedNCT03812029
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Efficacy of EYP001a in Patients With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Non-alcoholic Steatohepatitis
Enyo Pharma 120
Large-scale testing (Phase 3)UnknownNCT04193982
What this trial is testing

An Investigator Initiated Prospective, Four Arms Randomized Comparative Study of Efficacy and Safety of Saroglitazar, Vitamin E and Life Style Modification in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)/ Non-alcoholic Steatohepatitis (NASH)

Who this might be right for
NAFLD
Asian Institute of Gastroenterology, India 250
Not applicableUnknownNCT01281059
What this trial is testing

Prediction of Severity of Liver Disease Non Alcoholic Fatty Liver Disease in Patients With Suspected NAFLD by a 13C Octanoate Breath Test

Who this might be right for
NAFLD
Hadassah Medical Organization
Not applicableLooking for participantsNCT03025074
What this trial is testing

Blood Collection Biorepository for Liver Disease Research

Who this might be right for
Non-Alcoholic Steatohepatitis(NASH)Hepatitis CHepatitis B+5 more
State University of New York at Buffalo 1,000
Not applicableStudy completedNCT05946148
What this trial is testing

Novel Antidiabetic Medications and Their Effect on Liver Steatosis (NAMELS-18)

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseLiver Steatosis
National and Kapodistrian University of Athens 78
Not applicableStudy completedNCT03774511
What this trial is testing

Effects of Exercise on Patients With Nonalcoholic Fatty Liver Disease- A Comparative Randomized Controlled Trial

Who this might be right for
DiabetesNonalcoholic Fatty Liver DiseaseObesity+1 more
Ahlia University 48
Not applicableActive Not RecruitingNCT04820036
What this trial is testing

A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG)

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)Endoscopic Sleeve GastroplastyNon-alcoholic Fatty Liver Disease (NAFLD)+4 more
Brigham and Women's Hospital 20
Post-approval studies (Phase 4)Study completedNCT02875821
What this trial is testing

Effects of Ipragliflozin on Excessive Fat in Type 2 Diabetes Patients With Non-alcoholic Fatty Liver Disease Treated With Metformin and Pioglitazone

Who this might be right for
Type 2 Diabetes With Non-alcoholic Fatty Liver (NAFLD)
Yonsei University 44
Not applicableStudy completedNCT05764811
What this trial is testing

SGLT-2 Inhibitor Effects on Cardiac and Hepatic Metabolic Profiles for the Diabetes Patients Combined With Obesity

Who this might be right for
Fatty Liver Disease
National Cheng-Kung University Hospital 40
Next Page